ticagrelor

Generic: ticagrelor

Labeler: radha pharmaceuticals inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ticagrelor
Generic Name ticagrelor
Labeler radha pharmaceuticals inc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 90 mg/1

Manufacturer
Radha Pharmaceuticals INC

Identifiers & Regulatory

Product NDC 77771-522
Product ID 77771-522_436d09c3-b2d5-faac-e063-6394a90af799
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218962
Listing Expiration 2026-12-31
Marketing Start 2025-10-09

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 77771522
Hyphenated Format 77771-522

Supplemental Identifiers

RxCUI
1116635 1666332
UPC
0377771521608 0377771522605
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ticagrelor (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number ANDA218962 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 90 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (77771-522-60)
source: ndc

Packages (1)

Ingredients (1)

ticagrelor (90 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "436d09c3-b2d5-faac-e063-6394a90af799", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0377771521608", "0377771522605"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["436d1bef-da01-7d0a-e063-6294a90abd90"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Radha Pharmaceuticals INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (77771-522-60)", "package_ndc": "77771-522-60", "marketing_start_date": "20251009"}], "brand_name": "ticagrelor", "product_id": "77771-522_436d09c3-b2d5-faac-e063-6394a90af799", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "77771-522", "generic_name": "ticagrelor", "labeler_name": "Radha Pharmaceuticals INC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA218962", "marketing_category": "ANDA", "marketing_start_date": "20251009", "listing_expiration_date": "20261231"}